It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...

In this study, as the focus was broad pathogenic antibody profiling, we did not test antibody reactivity to autoantigens such as CRYAB and only speculated on possible cross-reactivity based on ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

The immune system must be able to quickly attack invaders like viruses, while also ignoring harmless stimuli, or allergies ...

The team created a novel tick antigen library housing over 3,000 different proteins, testing each to create a target cocktail ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Traumatically injured women are considerably less likely to receive whole blood transfusions within the first four hours of injury compared to men, despite whole blood being associated with reduced ...

I f you can't quite remember what your blood type is -- don't worry. That just means you're among the 33% of Americans who ...

The bispecific antibody helped people with small cell lung cancer live longer, Amgen said. Elsewhere, J&J shared new autoimmune drug data and Alzheon reported an Alzheimer’s drug failure.

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

Transient peripheral B-cell depletion and lymphocytopenia have been reported in infants born to mothers exposed to other anti-CD20 B-cell depleting antibodies during pregnancy. A pregnancy test is ...

With an arsenal of antibody assets based on IgE, IgA, and IgG, the newly combined company has opportunities across cancer indications.